Optimized Antibiotic Management of Critically Ill Patients with Severe Pneumonia Following Multiplex Polymerase Chain Reaction Testing: A Prospective Clinical Exploratory Trial

Optimized Antibiotic Management of Critically Ill Patients with Severe Pneumonia Following Multiplex Polymerase Chain Reaction Testing: A Prospective Clinical Exploratory Trial

Molecular diagnostic testing is assumed to enable fast respiratory pathogen identification and contribute to improved pneumonia management. We set up a prospective clinical trial at a tertiary hospital intensive care unit including adult patients suspected of severe pneumonia from whom a lower respi...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Alexia Verroken, Julien Favresse, Ahalieyah Anantharajah, Hector Rodriguez-Villalobos, Xavier Wittebole, Pierre-François Laterre
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: MDPI AG 2024-01-01
Sarja:Antibiotics
Aiheet:
severe pneumonia
molecular testing
FilmArray Pneumonia
antibiotic management
critically ill
antimicrobial stewardship
Linkit:https://www.mdpi.com/2079-6382/13/1/67

Samankaltaisia teoksia

Samankaltaisia teoksia